LMT vs STRO
Lockheed Martin Corporation (LMT) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Lockheed Martin Corporation (LMT) is a aerospace & defense company listed on US. It is led by Jim Taiclet.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported LMT revenue for 2025-12-31 was $75.05B. Net income was $5.02B. Revenue was up 5.6% from 2024-12-31 to 2025-12-31. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
LMT currently screens at market cap $108.37B and trailing P/E 19.9. STRO currently screens at market cap $470.8M.
Not investment advice. Open the LMT and STRO stock pages for the full models.
Not investment advice.